Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb’s Next Phase of Growth DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of […]
Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls. Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long […]
The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. […]
Uppsala, Sweden – Navinci Diagnostics AB today announces that the company has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response. The collaboration aims to evaluate how functional spatial readouts can be applied […]
Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif. — Slingshot Bio, Inc., a leader in precision cell mimic controls for flow cytometry, today announced the commercial launch of ViaComp® Ultra Amine, a next-generation compensation control designed for amine-reactive viability dyes and fluorophore-conjugated antibody panels in […]
Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS — 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing. Attrition in neurodegeneration remains among the highest […]
Newly-created Chief Technology Officer role marks a new chapter for bit.bio as the company expands its leadership team and technology portfolio The ioScreen platform enables pharmaceutical, biotechnology and in silico companies to access industrial-scale CRISPR screening in human stem cell-derived models without building specialist in-house capabilities Service gives researchers a more physiologically relevant way to […]
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK: SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the introduction of […]
Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer, more effective medicine Delivered in partnership with the National Centre for the Replacement, Refinement and Reduction […]
Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource. Scale: Approximately 5,500 research samples were analyzed using Olink technology. Access: The resulting data are available to researchers in PPMI’s repository. Purpose: The […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
